Bluechiip Ltd (ASX:BCT) is pleased to provide the Company's latest Investor Presentation.
Bluechiip's unique and patented technology combines secure wireless sample tracking with integrated temperature reading for use in extreme environments, working reliably in temperatures from -196DEG C to +200DEG C, and impervious to autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Based on MEMS technology, the Bluechiip(R) tag contains no electronics. Unlike traditional tracking technology like labels, barcodes or RFID, Bluechiip does not require line-of-sight visibility for temperature readings and tracking, and so can be read through frost without damaging the sample.
The tag can either be embedded or manufactured into storage products such as vials or bags. Easy identification, along with any associated information from the tag can be detected by a reader, which can also sense the temperature of the tagged items. Unlike other tracking methods, the Bluechiip(R) technology can sense the temperature of each item a tag is attached to or embedded in.
This technology is particularly important for industries such as the $2b biopreservation and cryopreservation market, which processes more than 300 million samples per year of tissue, blood, serum, plasma, etc., for industries such as pharmaceuticals, IVF, research and clinical trials. It also has applications in cold chain logistics, food, manufacturing, security and defence.
Further information is available at http://www.bluechiip.com
Bluechiip Ltd (ASX:BCT) is pleased to provide the script of the Open Briefing interview with the MD/CEO Andrew McLellan.
Bluechiip Ltd (ASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced it has entered a license and supply agreement with California-based Labcon North America, the world's leading manufacturer of earthfriendly laboratory consumables.
Bluechiip Ltd (ASX:BCT) is pleased to provide the Company's Half Yearly Report for the period ended 31 December, 2016.
Bluechiip Ltd (ASX:BCT) today released its quarterly cash flow report for the period ended 31 December 2016.
Bluechiip Ltd (ASX:BCT) is pleased to provide the script of the Open Briefing interview with the MD/CEO.
Bluechiip Ltd (ASX:BCT) is pleased to provide the company's AGM Presentation.
Bluechiip Ltd (ASX:BCT) today announced the company has received $50,000 in funding from Innovation Connections to proceed with the second phase of development of its 'overtemperature' chip technology with the University of Melbourne.
Bluechiip Ltd (ASX:BCT) today announced that it has sold three Starter Kits, which include Bluechiip readers and 4,000 associated consumables.
Bluechiip Ltd (ASX:BCT) is pleased to provide its Annual Report 2016 to shareholders.